MENU
PVLA
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION
Palvella Therapeutics (PVLA) Ownership - Who owns Palvella Therapeutics?
Palvella Therapeutics Inc is a late clinical-stage biopharmaceutical company committed to serving individuals suffering from serious, rare genetic skin diseases without approved therapies... Show more
Details
Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
244.11M
P/E Ratio
11.98
Total Cash
75.63M
Projected Growth
N/A
Total Debt
N/A
Revenue
N/A
Risk (Beta)
N/A
Dividend Yield
N/A
Total Cash/Share
6.84
Total Debt/Equity
N/A
Revenue/Share
null USD as % of share price
Fundamentals
PVLA
Capitalization
244M
P/E Ratio
11.98
Risk (Beta)
N/A
Dividend Yield
N/A
Total Cash
75.6M
Total Cash/Share
6.84
Total Debt
N/A
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
0%
Revenue
0
ROE
N/A
Book Value
55.6M
P/B Ratio
4.39
Cash Flow
N/A
Earnings
-2.08
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
11K
Current Ratio
8.84
Current Revenue Per Employee
N/A
Dividends Per Share - Security
N/A
EBITDA
-18.36M
Float
N/A
Float - Current
N/A
Gross Income Margin
N/A
Revenue To Assets
-53.34
Shares Held By Institutions
125M
Shares Outstanding - Current
11.1M
Total Liabilities
23.9M
Total Volume MTD
N/A
Value
N/A
Gain YTD
84.000
View a ticker or compare two or three
VS
VS
Show more...
Interact to see
Advertisement
Advertisement
A.I.Advisor
published price charts
A.I. Advisor
published General Information